US EditionPublished • loading... • Updated
Parnell Launches Nixiflor® - First Fda-Approved Generic Florfenicol + Flunixin Combination for Brd
The bioequivalent injectable combines antimicrobial and anti-inflammatory treatment in one dose, and Parnell says it can reduce labor and chute time.
Summary by The Bakersfield Californian
8 Articles
8 Articles
Grand Rapids Herald-Review+2 Reposted by 2 other sources
Parnell Technologies launches FDA-approved generic for bovine respiratory disease
Parnell Technologies Pty. Ltd. announced the U.S. launch of nixiFLOR (florfenicol and flunixin meglumine) injectable solution, recently approved by the U.S. Food and Drug Administration for the treatment of bovine respiratory disease (BRD) and control of BRD-associated fever in beef…
Rutland Herald+4 Reposted by 4 other sources
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Apr 1, 2026-
Coverage Details
Total News Sources8
Leaning Left2Leaning Right0Center3Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 40%
C 60%
Factuality
To view factuality data please Upgrade to Premium
